According to Neogen's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -41.2036. At the end of 2022 the company had a P/E ratio of 312.
Year | P/E ratio | Change |
---|---|---|
2022 | 312 | 269.09% |
2021 | 84.6 | 21.18% |
2020 | 69.8 | 22.24% |
2019 | 57.1 | 26.46% |
2018 | 45.2 | -25.81% |
2017 | 60.9 | -4.13% |
2016 | 63.5 | 6.1% |
2015 | 59.9 | 0.93% |
2014 | 59.3 | -0.69% |
2013 | 59.7 | 37.62% |
2012 | 43.4 | 33.47% |
2011 | 32.5 | -28.84% |
2010 | 45.7 | 32.02% |
2009 | 34.6 | 28.81% |
2008 | 26.9 | -23.79% |
2007 | 35.3 | 44.47% |
2006 | 24.4 | -20.42% |
2005 | 30.7 | -6.11% |
2004 | 32.7 | 10.94% |
2003 | 29.4 | 47.65% |
2002 | 19.9 | -32.82% |
2001 | 29.7 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.